Literature DB >> 28597369

First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.

Masahiro Takeyama1, Keiji Nogami2, Takahiro Kajimoto1, Kenichi Ogiwara1, Tomoko Matsumoto3, Midori Shima1.   

Abstract

We describe an 8-year-old boy with acquired hemophilia A (AHA) associated with streptococcal infection and amoxicillin. Laboratory data revealed low factor VIII activity (FVIII:C, 1.5 IU/dl), and FVIII inhibitor (15.9 BU/ml). Comprehensive coagulation function assays, including rotation thromboelastometry (ROTEM®), revealed a markedly prolonged clotting time. Thrombin and plasmin generation (TG/PG) appeared to be moderately impaired. The inhibitor epitope of his anti-FVIII autoantibody recognized light and heavy chains. He was treated with Novoseven® and prednisolone, resulting in rapid improvement. ROTEM showed the return of coagulation time to normal level on day 20, and TG gradually improved. PG was moderately reduced in the clinical early phase, but improved at day 20. The patient's IgG subtype was IgG4 at onset. IgG1 was transiently positive on day 20, but negative on day 46. FVIII inhibitor gradually decreased and was completely absent after day 46, along with the elevated FVIII:C. IgG4 was again elevated on day 83, followed by a rapid decrease, indicative of the presence of non-neutralizing antibody, which remains currently undetected. We for the first time report changes in comprehensive coagulation function and IgG subtype of anti-FVIII antibody in a rare pediatric case of AHA.

Entities:  

Keywords:  Acquired hemophila A; Children; Factor VIII; IgG; Inhibitor; Streptococcal infection

Mesh:

Substances:

Year:  2017        PMID: 28597369     DOI: 10.1007/s12185-017-2273-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease.

Authors:  T Matsumoto; M Shima; K Fukuda; K Nogami; J C Giddings; T Murakami; I Tanaka; A Yoshioka
Journal:  Thromb Res       Date:  2001-12-15       Impact factor: 3.944

2.  Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia A.

Authors:  M Takeyama; K Nogami; T Matsumoto; M Taguchi; K Yada; N Okahashi; I Amano; H Kimura; M Shima
Journal:  Haemophilia       Date:  2016-12-08       Impact factor: 4.287

3.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 4.  Acquired haemophilia A: a 2013 update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Thromb Haemost       Date:  2013-09-05       Impact factor: 5.249

5.  Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.

Authors:  Tomoko Matsumoto; Keiji Nogami; Midori Shima
Journal:  Thromb Haemost       Date:  2013-08-29       Impact factor: 5.249

6.  A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.

Authors:  Tomoko Matsumoto; Keiji Nogami; Kenichi Ogiwara; Midori Shima
Journal:  Thromb Haemost       Date:  2012-01-11       Impact factor: 5.249

7.  Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.

Authors:  Takashi Ishihara; Keiji Nogami; Tomoko Matsumoto; Akitaka Nomura; Yasufumi Takeshita; Satoshi Ochi; Midori Shima
Journal:  Int J Hematol       Date:  2017-03-16       Impact factor: 2.490

Review 8.  Phenotypic heterogeneity of hemostasis in severe hemophilia.

Authors:  Keiji Nogami; Midori Shima
Journal:  Semin Thromb Hemost       Date:  2015-01-23       Impact factor: 4.180

Review 9.  Immunoglobulin G4: an odd antibody.

Authors:  R C Aalberse; S O Stapel; J Schuurman; T Rispens
Journal:  Clin Exp Allergy       Date:  2009-02-13       Impact factor: 5.018

10.  Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

Authors:  Yoh Zen; Takahiko Fujii; Kenichi Harada; Mitsuhiro Kawano; Kazunori Yamada; Masayuki Takahira; Yasuni Nakanuma
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

View more
  1 in total

1.  Acquired Haemophilia A in Association with Influenza A and Urinary Tract Infection.

Authors:  Felipe Peña-Muñoz; Ernesto Parras; Olga Compan; Nora Gutiérrez; Celestino Martin; José Ramón González-Porras; Jose María Bastida
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.